REGENXBIO Inc.
RGNX | NASDAQ
$8.14
+$0.26 (+3.30%)
Sep 22, 2026, 11:59 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.83 | -1.68 | -2.98 | -3.49 | 10.86 | -15.22 |
PEG Ratio | 0.21 | 0.07 | 0.40 | 0.01 | -0.05 | -0.98 |
PS Ratio | 4.36 | 4.59 | 8.70 | 8.68 | 2.95 | 10.94 |
PB Ratio | 7.23 | 1.47 | 2.52 | 1.90 | 1.82 | 4.48 |
P/FCF Ratio | -5.88 | -2.18 | -3.44 | -4.11 | 10.30 | -20.90 |
P/OCF Ratio | -5.99 | -2.21 | -3.59 | -4.72 | 6.34 | -31.28 |
OCF/S Ratio | -72.73 | -207.76 | -242.02 | -184.07 | 46.53 | -34.98 |
Debt / Equity Ratio | 2.54 | 0.32 | 0.29 | 0.18 | 0.11 | 0.19 |
Quick Ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 | 6.39 |
Current Ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 | 6.52 |
Asset Turnover | 0.38 | 0.18 | 0.16 | 0.14 | 0.42 | 0.22 |
Interest Coverage | -3.58 | -18.43 | -39.07 | -11.30 | 6.09 | -154.65 |
Return on Equity | -188.72% | -87.46% | -84.52% | -54.31% | 16.73% | -29.45% |
Return on Assets | -42.80% | -48.74% | -45.91% | -33.64% | 11.48% | -15.71% |
Return on Invested Capital | -42.11% | -62.95% | -59.45% | -37.07% | 14.70% | -18.95% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88.09% | 59.72% | 58.76% | 51.61% | 88.98% | 76.89% |
Net Profit Margin | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% | -71.98% |
Pretax Profit Margin | -113.75% | -272.54% | -292.15% | -248.75% | 30.03% | -68.59% |
Operating Profit Margin | -94.58% | -280.03% | -297.12% | -233.20% | 34.01% | -77.14% |
FCF Margin | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% | -52.36% |
EBITDA Margin | -78.18% | -237.89% | -265.36% | -216.67% | 37.65% | -62.65% |
Add to Watchlist
Select watchlists to add or remove RGNX